FOXO1 and B-cell non-Hodgkin lymphoma: In fact, the upregulation of FOXO1 phosphorylation in gastric cancer correlates with better outcomes and FOXO1-activating mutations in B-cell lymphomas contribute to cancer progression [51,52].